Certified in the UK, EU, Switzerland, Norway, Hong Kong and Brazil since 2019
Pilots in 5 NHS Trusts and NHS Practitioner Health
Approved by the British Standards Institutions (BSI)
Class IIa medical device CE-marked
Tested according to IEC 60601 for electrical medical device safety
Join more than 300 private clinics and build Flow into your treatment pathway
Enter your email to download the guide
Mauris commodo turpis elit, sed dictum orci pharetra ac.
57.5% of study participants achieved remission in 10 weeks*
The recent EMPOWER clinical trial results, published in Nature Medicine, demonstrate Flow is effective and superior to the sham treatment1. This 10-week double-blind placebo-controlled randomised study reviewed the use of Flow compared to placebo across 173 adult participants diagnosed with unipolar depression (moderate to severe). Real-world data2 and various ongoing pilots3 show similar results.The EMPOWER trial also highlighted a potential amplification when Flow was used in combination with an antidepressant. This impact has also been reported in real-world cases. *Remission defined as a score of ≤12 on MADRS
